Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Idilman

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Minerva Gastroenterologica E Dietologica|March 24, 2006
Anti-viral prophylaxis in inactive hepatitis B virus carriers with hemato-oncological malignancies who receive chemotherapyR Idilman
Gut|July 20, 2006
Duration of lamivudine prophylaxis in inactive hepatitis B virus carriers with haemato/oncological malignancies who receive chemotherapyR Idilman
Cancer|January 28, 1999
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphomaM Beksaç, M Arat, R Idilman
Journal of Viral Hepatitis|August 21, 2010
Natural history and treatment of chronic delta hepatitisC Yurdaydın, R Idilman, H Bozkaya, et al.
Hepato-Gastroenterology|December 5, 1998
Liver transplantation for chronic viral liver diseaseA Colantoni, T Hassanein, R Idilman, et al.
Journal of Viral Hepatitis|September 14, 2001
Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosisN De Maria, R Idilman, A Colantoni, et al.
Clinical Radiology|July 16, 2021
The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary studyI S Idilman, A Celik, B Savas, et al.
Italian Journal of Gastroenterology and Hepatology|June 1, 1997
Polymerase chain reaction for the detection of HCV-RNA: cryoglobulinaemia as a cause for false negative resultsA Colantoni, N De Maria, R Idilman, et al.
Hepato-Gastroenterology|June 25, 1998
Current and future therapies for HCV infection: what should the end point for treatment be?D H Van Thiel, N De Maria, A Colantoni, et al.
Hepato-Gastroenterology|June 25, 1998
Interferon treatment of HCV positive cirrhotic patientsR Idilman, A Colantoni, N De Maria, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Minerva Gastroenterologica E Dietologica|March 24, 2006
Anti-viral prophylaxis in inactive hepatitis B virus carriers with hemato-oncological malignancies who receive chemotherapyR Idilman
Gut|July 20, 2006
Duration of lamivudine prophylaxis in inactive hepatitis B virus carriers with haemato/oncological malignancies who receive chemotherapyR Idilman
Cancer|January 28, 1999
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphomaM Beksaç, M Arat, R Idilman
Journal of Viral Hepatitis|August 21, 2010
Natural history and treatment of chronic delta hepatitisC Yurdaydın, R Idilman, H Bozkaya, et al.
Hepato-Gastroenterology|December 5, 1998
Liver transplantation for chronic viral liver diseaseA Colantoni, T Hassanein, R Idilman, et al.
Journal of Viral Hepatitis|September 14, 2001
Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosisN De Maria, R Idilman, A Colantoni, et al.
Clinical Radiology|July 16, 2021
The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary studyI S Idilman, A Celik, B Savas, et al.
Italian Journal of Gastroenterology and Hepatology|June 1, 1997
Polymerase chain reaction for the detection of HCV-RNA: cryoglobulinaemia as a cause for false negative resultsA Colantoni, N De Maria, R Idilman, et al.
Hepato-Gastroenterology|June 25, 1998
Current and future therapies for HCV infection: what should the end point for treatment be?D H Van Thiel, N De Maria, A Colantoni, et al.
Hepato-Gastroenterology|June 25, 1998
Interferon treatment of HCV positive cirrhotic patientsR Idilman, A Colantoni, N De Maria, et al.
Pageof 5